Expected Moves

Body One is expected to report Q3 earnings, revealing if the company can stem its significant EBITDA cash burn and justify a staggering 21.3x Price-to-Sales multiple. We model a base-case decline to $0.55 on continued fundamental weakness, while a surprise turnaround could test the $0.95 level.

A critical interim update on holiday retail performance. Operating in the highly cyclical apparel space, Body One needs robust Q4 volumes to offset fixed costs. Upside to $0.75 relies on volume moving at full price, while a miss likely pushes the stock to $0.40.

Given negative operating cash flows, the FY26 print will likely pair with a necessary capital raise or dilutive financing announcement. The stock could rebound to $0.60 if non-dilutive financing is secured, but the base case suggests a plunge to $0.20 on a heavily discounted equity offering.

First quarter results will demonstrate whether earlier restructuring efforts or capital injections have stabilized operations. A favorable margin recovery could lift shares to $0.35, whereas persistent cash burn risks pushing the valuation toward a $0.10 shell-value floor.